Related Experiment Video
Updated: May 4, 2026
04:48
Control of Eating Behavior Using a Novel Feedback System
Published on: May 8, 2018
11.9K
Evaluating eating behavior treatments by FDA standards.
A Janet Tomiyama1, Britt Ahlstrom2, Traci Mann3
1Department of Psychology, University of California Los Angeles, Los Angeles, CA, USA.
Frontiers in Psychology
|January 16, 2014
Summary
Behavioral obesity treatments like dieting should be evaluated using the same safety and effectiveness criteria as drugs. Applying the Food and Drug Administration (FDA) framework can reveal research gaps in behavioral medicine.
Area of Science:
- Behavioral Medicine
- Obesity Treatment
- Health Policy
Background:
- Behavioral obesity treatments, such as low-calorie dieting, are widely used but not held to the same evaluation standards as pharmaceutical drugs.
- These interventions demand significant patient time and resources and carry potential risks.
Purpose of the Study:
- To propose applying the Food and Drug Administration (FDA) drug evaluation framework to behavioral interventions for obesity.
- To highlight how this framework can identify critical research questions regarding the efficacy and effectiveness of behavioral treatments.
Main Methods:
- The study discusses the FDA's four-question framework for drug evaluation: safety, condition severity, effectiveness, and population-wide safety/effectiveness.
- It applies this framework conceptually to behavioral interventions, using low-calorie dieting as a case example.
Main Results:
- The FDA framework provides a structured approach to assess behavioral treatments, similar to pharmaceutical evaluations.
- Applying these criteria to low-calorie dieting reveals areas needing further research on its efficacy and effectiveness.
Conclusions:
- A standardized evaluation framework, like the FDA's, is needed for behavioral obesity treatments.
- Adopting such criteria can advance research and ensure patient safety and treatment effectiveness in behavioral medicine.
Related Concept Videos
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
01:11Clinical Trials: Overview
4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
01:16Clinical Trials
8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
8.5K
01:23Binge Eating Disorders
828
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
828
01:26FDA Approved Drugs: Changes to Approved Drugs
343
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
343